Report of Foreign Issuer (6-k)
December 14 2017 - 7:38AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Section 13a-16 or 15d-16 of the Securities Exchange Act of 1934
For the month of December 2017
Commission File Number: 001-37569
STRONGBRIDGE BIOPHARMA plc
(Exact name of Registrant as specified in its charter)
900 Northbrook Drive
Suite 200
Trevose, PA 19053
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
x
Form 40-F
o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
o
On December 14, 2017, Strongbridge Biopharma plc (the
Registrant
) issued a press release regarding new employment inducement awards.
The information contained in the press release is being furnished to the Commission and shall not be deemed incorporated by reference into any of the Registrants registration statements or other filings with the Commission.
Exhibits
Exhibit
Number
|
|
Exhibit Table
|
|
|
|
99.1
|
|
Press Release issued by Strongbridge Biopharma plc, dated December 14, 2017.
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Dated: December 14, 2017
|
STRONGBRIDGE BIOPHARMA PLC
|
|
|
|
|
|
By:
|
/s/ Stephen Long
|
|
|
Stephen Long
|
|
|
Chief Legal Officer
|
3
Strongbridge Biopharma (NASDAQ:SBBP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Strongbridge Biopharma (NASDAQ:SBBP)
Historical Stock Chart
From Apr 2023 to Apr 2024